First National Bank of Mount Dora’s Teva Pharmaceuticals TEVA Stock Holding History

First National Bank of Mount Dora’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-24,775	Closed	-$898K	–	80
2016 Q4	$898K	Sell	24,775 -3,896	-14%	-$156K	0.53%	55
2016 Q3	$1.32M	Sell	28,671 -17,964	-39%	-$937K	0.74%	53
2016 Q2	$2.34M	Buy	46,635 +2,141	+5%	+$114K	1.34%	34
2016 Q1	$2.38M	Sell	44,494 -800	-2%	-$46.9K	1.4%	32
2015 Q4	$2.97M	Buy	45,294 +255	+0.6%	+$15.8K	1.75%	27
2015 Q3	$2.54M	Sell	45,039 -805	-2%	-$52.2K	1.56%	27
2015 Q2	$2.71M	Buy	45,844 +200	+0.4%	+$12.3K	1.51%	28
2015 Q1	$2.84M	Buy	45,644 +13,225	+41%	+$769K	1.54%	27
2014 Q4	$1.86M	Sell	32,419 -11,076	-25%	-$617K	1.04%	39
2014 Q3	$2.34M	Buy	43,495 +450	+1%	+$23.8K	1.37%	29
2014 Q2	$2.26M	Buy	43,045 +2,250	+6%	+$115K	1.31%	31
2014 Q1	$2.15M	Buy	40,795 +6,274	+18%	+$290K	1.31%	28
2013 Q4	$1.38M	Buy	34,521 +925	+3%	+$36.4K	0.9%	44
2013 Q3	$1.27M	Sell	33,596 -400	-1%	-$15.6K	0.93%	41
2013 Q2	$1.33M	Buy	+33,996	New	+$1.32M	0.99%	39

Other funds holding TEVA

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

HCM

Highfields Capital Management Boston, Massachusetts $68.3M AUM 21.64% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Northern Cross Boston, Massachusetts $279M AUM 1.98% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

First National Bank of Mount Dora's TEVA Position: Q1 2017 in Review

First National Bank of Mount Dora sold out of Teva Pharmaceuticals (TEVA) in Q1 2017, closing a stake of 24,775 shares — an estimated $898K sold.

First National Bank of Mount Dora first reported a position in TEVA in Q2 2013 and held it in 15 quarters. The position peaked at $2.97M in Q4 2015. 687 funds tracked by Wall St. Rank hold TEVA as of Q1 2017.

First National Bank of Mount Dora reported no remaining Teva Pharmaceuticals position as of Q1 2017 after selling out during the quarter.
First National Bank of Mount Dora sold 24,775 Teva Pharmaceuticals shares in Q1 2017, an estimated $898K.
First National Bank of Mount Dora first reported a position in Teva Pharmaceuticals in Q2 2013 and held it in 15 quarters.
First National Bank of Mount Dora's Teva Pharmaceuticals position peaked at $2.97M in Q4 2015.
687 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q1 2017.

Based on First National Bank of Mount Dora's 13F filing for Q1 2017, filed 10 Apr 2017.